MedPath

Simulated In-House Usability Study of Eclipse Continuous Positive Airway Pressure (CPAP) Device

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Device: Eclipse novel CPAP mask
Device: Phillips Respironics Nuance
Registration Number
NCT05570747
Lead Sponsor
Bleep, LLC
Brief Summary

The study is designed to assess the usability of a novel CPAP human interface compared to a traditional nasal mask. Human subjects will interact with two different CPAP interfaces including a traditional CPAP mask and the 2nd generation DreamPort-Eclipse. Subjects will be requested to put on each of the different CPAP interface options a total of three times for a total of 6 trials. The order of device will be randomized.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Male or female ≥18 years old who are impacted by obstructive sleep apnea and currently are familiar with a CPAP device.
Exclusion Criteria
  • Diagnosis of any medical or behavioral conditions that would compromise subject safety.
  • Under the age of 18: target for this current version of the platform is the adult population.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
In-House Usability Study GroupPhillips Respironics NuanceHuman subjects will interact with two different CPAP interfaces including a traditional CPAP mask and the 2nd generation DreamPort-Eclipse. Subjects will be requested to put on each of the different CPAP interface options a total of three times for a total of 6 trials. The order of device tries will be randomized.
In-House Usability Study GroupEclipse novel CPAP maskHuman subjects will interact with two different CPAP interfaces including a traditional CPAP mask and the 2nd generation DreamPort-Eclipse. Subjects will be requested to put on each of the different CPAP interface options a total of three times for a total of 6 trials. The order of device tries will be randomized.
Primary Outcome Measures
NameTimeMethod
Time to complete each setup1 day

Investigators will record the time it takes the participant to set up and try on each device.

Number of technical issues1 day

Investigators will record the number of observed technical issues that occurred when the participant attempts to set up and try on the device.

Number of times participant needs assistance1 day

Investigators will record the number of times each participant requires assistance or additional instructions setting up and trying on each device.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Sleep Centers of Middle Tennessee

🇺🇸

Murfreesboro, Tennessee, United States

Advanced Respiratory and Sleep Medicine

🇺🇸

Huntersville, North Carolina, United States

AeroFlow Sleep

🇺🇸

Asheville, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath